Detalles de la búsqueda
1.
[Prognostic significance of DEK-NUP214 fusion gene in patients with acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation].
Zhonghua Nei Ke Za Zhi
; 60(10): 868-874, 2021 Oct 01.
Artículo
en Zh
| MEDLINE | ID: mdl-34551474
2.
[Analysis of the influential factors of late diagnosis among newly identified HIV/AIDS cases in Anhui Province, 2011-2015].
Zhonghua Yu Fang Yi Xue Za Zhi
; 52(4): 415-418, 2018 Apr 06.
Artículo
en Zh
| MEDLINE | ID: mdl-29614610
3.
[Experts consensus on the management of the right heart function in critically ill patients].
Zhonghua Nei Ke Za Zhi
; 56(12): 962-973, 2017 Dec 01.
Artículo
en Zh
| MEDLINE | ID: mdl-29202543
4.
[Clinical features and early treatment effects in intermediate risk and poor risk acute myeloid leukemia with EVI1 positive].
Beijing Da Xue Xue Bao Yi Xue Ban
; 49(6): 990-995, 2017 Dec 18.
Artículo
en Zh
| MEDLINE | ID: mdl-29263470
5.
CTLA-4 polymorphisms and haplotype correlate with survival in ALL after allogeneic stem cell transplantation from related HLA-haplotype-mismatched donor.
J Transl Med
; 14: 100, 2016 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-27118383
6.
[A comparison of efficacy and safety between Chinese generic imatinib versus branded imatinib in patients with newly-diagnosed chronic myeloid leukemia in the chronic phase: a single-center prospective cohort study].
Zhonghua Nei Ke Za Zhi
; 55(12): 922-926, 2016 Dec 01.
Artículo
en Zh
| MEDLINE | ID: mdl-27916045
7.
Hypothyroidism and first-trimester spontaneous miscarriages.
Clin Exp Obstet Gynecol
; 41(2): 182-5, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24779248
8.
[Factors influencing severe cytopenia in chronic phase chronic myeloid leukemia patients receiving initial second generation tyrosine kinase inhibitors and its impact on treatment responses and outcomes].
Zhonghua Xue Ye Xue Za Zhi
; 44(4): 295-301, 2023 Apr 14.
Artículo
en Zh
| MEDLINE | ID: mdl-37356998
9.
[Comparison of BCR::ABL (P210) mRNA levels detected by dPCR and qPCR methods in patients with chronic myeloid leukemia].
Zhonghua Xue Ye Xue Za Zhi
; 44(11): 906-910, 2023 Nov 14.
Artículo
en Zh
| MEDLINE | ID: mdl-38185519
10.
[Combination of socio-demographic and clinical co-variates for predicting treatment responses and outcomes in patients with chronic myeloid leukemia in the chronic phase].
Zhonghua Xue Ye Xue Za Zhi
; 43(1): 54-62, 2022 Jan 14.
Artículo
en Zh
| MEDLINE | ID: mdl-35231994
11.
[The efficacy and safety of low-dose chemotherapy combined with tyrosine kinase inhibitors in the treatment of Philadelphia-chromosomal-positive acute lymphoblastic leukemia].
Zhonghua Xue Ye Xue Za Zhi
; 43(7): 550-556, 2022 Jul 14.
Artículo
en Zh
| MEDLINE | ID: mdl-36709131
12.
[Clinical characteristics, treatment pattern, and outcomes in newly diagnosed patients with chronic myeloid leukemia in the chronic phase by age].
Zhonghua Xue Ye Xue Za Zhi
; 42(2): 101-108, 2021 Feb 14.
Artículo
en Zh
| MEDLINE | ID: mdl-33858039
13.
[Analysis of the clinical characteristics of 24 cases of hematological malignancies with SET-NUP214 fusion gene].
Zhonghua Xue Ye Xue Za Zhi
; 42(6): 459-465, 2021 Jun 14.
Artículo
en Zh
| MEDLINE | ID: mdl-34384151
14.
[Variables associated with BCR-ABL kinase domain mutation in TKI-resistant patients with chronic myeloid leukemia].
Zhonghua Xue Ye Xue Za Zhi
; 41(6): 469-476, 2020 Jun 14.
Artículo
en Zh
| MEDLINE | ID: mdl-32654459
15.
[Dasatinib-related pulmonary adverse events in patients with chronic myeloid leukemia].
Zhonghua Xue Ye Xue Za Zhi
; 41(12): 1013-1019, 2020 Dec 14.
Artículo
en Zh
| MEDLINE | ID: mdl-33445849
16.
[Analysis of the efficacy and influencing factors of nilotinib or dasatinib as second- or third-line treatment in patients with chronic myeloid leukemia in the chronic phase and accelerated phase].
Zhonghua Xue Ye Xue Za Zhi
; 41(2): 93-99, 2020 Feb 14.
Artículo
en Zh
| MEDLINE | ID: mdl-32135623
17.
Correlations of the ZEB1 expression with the incidence and prognosis of non-small cell lung cancer.
Eur Rev Med Pharmacol Sci
; 23(4): 1528-1535, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30840275
18.
[Fertility and disease outcomes in patients with chronic myeloid leukemia].
Zhonghua Xue Ye Xue Za Zhi
; 40(12): 980-985, 2019 Dec 14.
Artículo
en Zh
| MEDLINE | ID: mdl-32023726
19.
[Comparison of nilotinib vs imatinib as frontline therapy in newly diagnosed patients with chronic myeloid leukemia in chronic phase].
Zhonghua Xue Ye Xue Za Zhi
; 40(12): 996-1002, 2019 Dec 14.
Artículo
en Zh
| MEDLINE | ID: mdl-32023729
20.
[Philadelphia chromosome-negative myeloid neoplasms in patients with Philadelphia chromosome-positive chronic myeloid leukemia during tyrosine kinase inhibtor-therapy].
Zhonghua Xue Ye Xue Za Zhi
; 40(7): 547-553, 2019 Jul 14.
Artículo
en Zh
| MEDLINE | ID: mdl-32397016